KLF7 and non-small cell lung carcinoma: Engineered MSC-exos transport and deliver miR-204 to act on NSCLC cells, and the overexpression of miR-204 inhibits KLF7 expression and AKT/HIF-1α pathway activity, thereby inhibiting NSCLC migration and invasion [73].